Maxipime

Known as: Bristol-Myers brand of cefepime dihydrochloride, Axépim, Elan brand of cefepime dihydrochloride 
 

Topic mentions per year

Topic mentions per year

1997-2010
02419972010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
The metabolism of drugs is altered in dialysed patients. We report three clinical cases of neurological toxicity from cefepime in… (More)
Is this relevant?
2007
2007
It was demonstrated that bifidobacteria and lactic acid bacteria B. adolescentis and Lactobacillus sp. synthesized extracellular… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
Is this relevant?
2006
2006
The aim of our work was to confirm the effectiveness of the IV generation cephalosporin maxipime. Patients with sepsis… (More)
Is this relevant?
2005
2005
OBJECTIVE To evaluate the therapeutic effects and safety of cefepime (Maxipime) and sulbactam/cefoperazone (sulperazone) on… (More)
Is this relevant?
2003
2003
Cefepime (Maxipime, Bristol-Myers Squibb), a 4th generation cephalosporin was used in the postoperative treatment of 121 patients… (More)
Is this relevant?
2003
2003
Comparative susceptibility of microflora isolates from patients with complicated urinary tract infections to cefepime, other… (More)
Is this relevant?
2002
2002
Between September and December 2001 in the "Caritas" Surgical Clinic of Bucharest has been conducted a clinical study for the… (More)
Is this relevant?
2002
2002
BACKGROUND The aim of the present study was to investigate the clinical and bacteriological efficacy of Cefepime administered to… (More)
Is this relevant?
Review
2001
Review
2001
As a result of the appearance of bacterial strains resistant to 3rd generation cephlosporin, since 1993 cephalosporins of 4th… (More)
Is this relevant?